Cargando…
Tumor-associated autoantibodies as diagnostic and prognostic biomarkers
In the process of tumorigenesis, normal cells are remodeled to cancer cells and protein expression patterns are changed to those of tumor cells. A newly formed tumor microenvironment elicits the immune system and, as a result, a humoral immune response takes place. Although the tumor antigens are un...
Autores principales: | Heo, Chang-Kyu, Bahk, Young Yil, Cho, Eun-Wie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133814/ https://www.ncbi.nlm.nih.gov/pubmed/23261052 http://dx.doi.org/10.5483/BMBRep.2012.45.12.236 |
Ejemplares similares
-
Cyclic Peptide Mimotopes for the Detection of Serum Anti–ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma
por: Heo, Chang-Kyu, et al.
Publicado: (2020) -
Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma
por: Heo, Chang-Kyu, et al.
Publicado: (2019) -
Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide-conjugated BSA
por: Heo, Chang-Kyu, et al.
Publicado: (2022) -
Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma
por: Hwang, Hai-Min, et al.
Publicado: (2018) -
Autoantibody Biomarkers in Rheumatic Diseases
por: Kang, Eun Ha, et al.
Publicado: (2020)